FDA's Executive Responsibility Policy Could Sweep Up Board Members
This article was originally published in The Tan Sheet
Executive Summary
Add board members to the list of company executives who could be personally affected by FDA's plans to focus on responsible individuals in the corporations it takes to task as part of its enforcement mission
You may also be interested in...
Park Doctrine Influence Could Wane In Upcoming Cases, Attorney Argues
As penalties increase under the responsible corporate officer doctrine, attorney Allison Burroughs says to expect increased scrutiny. A DoJ Consumer Protection Branch official says pharma execs will be held responsible because of the role the industry plays in consumers’ daily lives.
Park Doctrine Influence Could Wane In Upcoming Cases, Attorney Argues
As penalties increase under the responsible corporate officer doctrine, attorney Allison Burroughs says to expect increased scrutiny. A DoJ Consumer Protection Branch official says pharma execs will be held responsible because of the role the industry plays in consumers’ daily lives.
FDA Targets Executives With Powerful Misdemeanor Strategy
Executives could face virtually unbeatable government criminal prosecutions and prison sentences more frequently if FDA follows recently announced enforcement plans, industry attorneys warn